wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50073683-70E1A6C6-8DEC-41C5-9FA5-FAFA31FCD687
Q50073683-70E1A6C6-8DEC-41C5-9FA5-FAFA31FCD687
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50073683-70E1A6C6-8DEC-41C5-9FA5-FAFA31FCD687
A review on biosimilar infliximab, CT-P13, in the treatment of inflammatory bowel disease.
P2860
Q50073683-70E1A6C6-8DEC-41C5-9FA5-FAFA31FCD687
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50073683-70E1A6C6-8DEC-41C5-9FA5-FAFA31FCD687
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1e5db0e741fefc18e8c78d6902eb2fba77d86d89
P2860
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.